Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31Investment holding company.truetrue2024-01-01false11truefalsefalse 14110898 2024-01-01 2024-12-31 14110898 2023-01-01 2023-12-31 14110898 2024-12-31 14110898 2023-12-31 14110898 2023-01-01 14110898 5 2024-01-01 2024-12-31 14110898 5 2023-01-01 2023-12-31 14110898 6 2024-01-01 2024-12-31 14110898 6 2023-01-01 2023-12-31 14110898 d:Director1 2024-01-01 2024-12-31 14110898 d:RegisteredOffice 2024-01-01 2024-12-31 14110898 e:CurrentFinancialInstruments 2024-12-31 14110898 e:CurrentFinancialInstruments 2023-12-31 14110898 e:CurrentFinancialInstruments e:WithinOneYear 2024-12-31 14110898 e:CurrentFinancialInstruments e:WithinOneYear 2023-12-31 14110898 e:ShareCapital 2024-01-01 2024-12-31 14110898 e:ShareCapital 2024-12-31 14110898 e:ShareCapital 2023-01-01 2023-12-31 14110898 e:ShareCapital 2023-12-31 14110898 e:ShareCapital 2023-01-01 14110898 e:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 14110898 e:RetainedEarningsAccumulatedLosses 2024-12-31 14110898 e:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 14110898 e:RetainedEarningsAccumulatedLosses 2023-12-31 14110898 e:RetainedEarningsAccumulatedLosses 2023-01-01 14110898 d:OrdinaryShareClass1 2024-01-01 2024-12-31 14110898 d:OrdinaryShareClass1 2024-12-31 14110898 d:OrdinaryShareClass1 2023-12-31 14110898 d:FRS102 2024-01-01 2024-12-31 14110898 d:Audited 2024-01-01 2024-12-31 14110898 d:FullAccounts 2024-01-01 2024-12-31 14110898 d:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 14110898 e:Subsidiary1 2024-01-01 2024-12-31 14110898 e:Subsidiary1 1 2024-01-01 2024-12-31 14110898 e:Subsidiary2 2024-01-01 2024-12-31 14110898 e:Subsidiary2 1 2024-01-01 2024-12-31 14110898 2 2024-01-01 2024-12-31 14110898 6 2024-01-01 2024-12-31 14110898 f:PoundSterling 2024-01-01 2024-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 14110898










VIVERSE LIMITED










ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

 
VIVERSE LIMITED
 
 
COMPANY INFORMATION


Director
Hsiueh Hong Wang 




Registered number
14110898



Registered office
Salamanca
Wellington Street, Slough

Berkshire

SL1 1YP




Independent auditors
Sumer Auditco Limited
Chartered Accountants & Statutory Auditors

14th Floor

33 Cavendish Square

London

W1G 0PW





 
VIVERSE LIMITED
 

CONTENTS



Page
Strategic report
1
Director's report
2 - 3
Independent auditors' report
4 - 7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Notes to the financial statements
11 - 20


 
VIVERSE LIMITED
 
 
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

Introduction
 
The directors present their report and financial statements for the year ended 31 December 2024.

Business review
 
The principal activity of the Company during the period was that of an investment holding company.
The Company is part of a wider group headed by HTC Corporation. 
The principal activity of its subsidiaries is that of providing VR research, developments and platform service. 
During the reporting period, the company incurred only minimum expenses to maintain the existence of the company and made a provision of impairment £8.7m (2023: £13.5m) on investments in subsidiaries. As a result, loss before taxation for the year amounted to £8,686,434 compared to a loss of £13,755,729 in 2023. 

Principal risks and uncertainties
 
The Company's financial instruments principally comprise of cash at bank. It is, and has been throughout the period under review, the Company's policy that no trading in financial instruments should be undertaken. The Company has limited exposure to financial risks, which are principally liquidity and cash flow risk:
Liquidity and cash flow risk
While the Company has no external borrowing, the management review the cashflow across the group on a regular basis to ensure operating needs of its subsidiaries are met.

Financial key performance indicators
 
As an intermediate holding company, the company does not have any key performance indicators. 


This report was approved by the board and signed on its behalf.



Hsiueh Hong Wang
Director

Date: 30 December 2025

Page 1

 
VIVERSE LIMITED
 
 
 
DIRECTOR'S REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

The director presents her report and the financial statements for the year ended 31 December 2024.

Director's responsibilities statement

The director is responsible for preparing the Strategic report, the Director's report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the director must not approve the financial statements unless she is satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 In preparing these financial statements, the director is required to:


select suitable accounting policies for the Company's financial statements and then apply them consistently;

make judgments and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable her to ensure that the financial statements comply with the Companies Act 2006She is also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Results and dividends

The loss for the year, after taxation, amounted to £8,686,434 (2023 - loss £13,755,729).

Director

The director who served during the year was:

Hsiueh Hong Wang 

Future developments

The directors do not expect any changes in the near future. 

Matters covered in the Strategic report

Relevant disclosures relating to principal risks and uncertainties are also included in the strategic report. 

Page 2

 
VIVERSE LIMITED
 
 
 
DIRECTOR'S REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024

Disclosure of information to auditors

The director at the time when this Director's report is approved has confirmed that:
 
so far as she is aware, there is no relevant audit information of which the Company's auditors are unaware, and

she has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company's auditors are aware of that information.

Auditors

The auditorsSumer Auditco Limitedwill be proposed for reappointment in accordance with section 485 of the Companies Act 2006.

This report was approved by the board and signed on its behalf.
 





Hsiueh Hong Wang
Director
Date: 30 December 2025

Page 3

 
VIVERSE LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF VIVERSE LIMITED
 

Opinion


We have audited the financial statements of Viverse Limited (the 'Company') for the year ended 31 December 2024, which comprise the Statement of comprehensive income, the Balance sheet, the Statement of changes in equity and the related notes, including a summary of significant accounting policiesThe financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).


In our opinion the financial statements:


give a true and fair view of the state of the Company's affairs as at 31 December 2024 and of its loss for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.


Basis for opinion


We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


Conclusions relating to going concern


In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.


Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.


Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.


Page 4

 
VIVERSE LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF VIVERSE LIMITED (CONTINUED)


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' report thereon. The director is responsible for the other information contained within the Annual ReportOur opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Opinion on other matters prescribed by the Companies Act 2006
 

In our opinion, based on the work undertaken in the course of the audit:


the information given in the Strategic report and the Director's report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the Strategic report and the Director's report have been prepared in accordance with applicable legal requirements.


Matters on which we are required to report by exception
 

In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic report or the Director's report.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of director's remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.


Responsibilities of directors
 

As explained more fully in the Director's responsibilities statement set out on page 2, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the director is responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.


Auditors' responsibilities for the audit of the financial statements
Page 5

 
VIVERSE LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF VIVERSE LIMITED (CONTINUED)


 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.


Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

In order to identify and assess the risks of material misstatements, including fraud and noncompliance with laws and regulations that could be expected to have a material impact on the financial statements, we have considered:

the results of our enquiries of management and those charged with governance of their assessment of the risks of fraud and irregularities;
the nature of the company, including its management structure and control systems (including the opportunity for management to override such controls); and
the industry and environment in which it operates.

We also considered UK tax legislation and laws and regulations relating to the preparation and presentation of the financial statements such as the Companies Act 2006.

Based on this understanding we identified the following matters as being of significance to the entity:

laws and regulations considered to have a direct effect on the financial statements including UK financial reporting standards, Company Law, tax legislation and distributable profits legislation; 
management bias in selecting accounting policies and determining estimates; and
the requirement to impair investments in the subsidiary and the amount of any such impairment.

We communicated the outcomes of these discussions and enquiries, as well as consideration as to where and how fraud may occur in the entity, to all engagement team members.

Audit procedures undertaken in response to the potential risks relating to irregularities (which include fraud and non-compliance with laws and regulations) comprised:

 
enquiries of management and those charged with as to whether the entity complies with such laws and regulations;
enquiries with the same concerning any actual or potential litigation or claims;
discussion with the same regarding any known or suspected instances of non-compliance with laws and regulation and fraud;
assessment of matters reported to management and the result of the subsequent investigation;
challenging assumptions made by management in their specific accounting policies and estimates, in particular in relation to impairment of investments;
reviewing the financial statements for compliance with the relevant disclosure requirements;
performing analytical procedures to identify any unusual or unexpected relationships or unexpected movements in account balances which may be indicative of fraud;
reviewing the minutes of Board meetings and correspondence with HMRC; and
evaluating the underlying business reasons for any unusual transactions.
Page 6

 
VIVERSE LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF VIVERSE LIMITED (CONTINUED)



No instances of material non-compliance were identified. However, the likelihood of detecting irregularities, including fraud, is limited by the inherent difficulty in detecting irregularities, the effectiveness of the entity’s controls, and the nature, timing and extent of the audit procedures performed. Irregularities that result from fraud might be inherently more difficult to detect than irregularities that result from error. As explained above, there is an unavoidable risk that material misstatements may not be detected, even though the audit has been planned and performed in accordance with ISAs (UK).
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' report.


Use of our report
 

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.





Andrew Marks ACA, FCCA (Senior statutory auditor)
  
for and on behalf of
Sumer Auditco Limited
 
Chartered Accountants
Statutory Auditors
  
14th Floor
33 Cavendish Square
London
W1G 0PW

30 December 2025
Page 7

 
VIVERSE LIMITED
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024

2024
2023
£
£

  

Administrative expenses
  
1,080
(281,750)

Operating profit/(loss)
  
1,080
(281,750)

Amounts written off investments
  
(8,687,527)
(13,473,992)

Interest receivable and similar income
  
13
18

Interest payable and similar expenses
  
-
(5)

Loss before tax
  
(8,686,434)
(13,755,729)

Loss for the financial year
  
(8,686,434)
(13,755,729)

There was no other comprehensive income for 2024 (2023:£NIL).

The notes on pages 11 to 20 form part of these financial statements.

Page 8

 
VIVERSE LIMITED
REGISTERED NUMBER: 14110898

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Investments
 10 
17,063,576
6,788,463

  
17,063,576
6,788,463

Current assets
  

Debtors: amounts falling due within one year
 11 
2,741
1

Cash at bank and in hand
 12 
842,837
838,740

  
845,578
838,741

Creditors: amounts falling due within one year
 13 
(14,806)
(9,062)

Net current assets
  
 
 
830,772
 
 
829,679

Total assets less current liabilities
  
17,894,348
7,618,142

  

Net assets
  
17,894,348
7,618,142


Capital and reserves
  

Called up share capital 
  
40,335,545
21,372,905

Profit and loss account
 15 
(22,441,197)
(13,754,763)

  
17,894,348
7,618,142


The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Hsiueh Hong Wang
Director

Date: 30 December 2025

The notes on pages 11 to 20 form part of these financial statements.

Page 9

 
VIVERSE LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024


Called up share capital
Profit and loss account
Total equity

£
£
£

At 1 January 2024
21,372,905
(13,754,763)
7,618,142


Comprehensive income for the year

Loss for the year
-
(8,686,434)
(8,686,434)

Shares issued during the year
18,962,640
-
18,962,640


At 31 December 2024
40,335,545
(22,441,197)
17,894,348


The notes on pages 11 to 20 form part of these financial statements.


STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2023


Called up share capital
Profit and loss account
Total equity

£
£
£

At 1 January 2023
4,022,705
966
4,023,671


Comprehensive income for the year

Loss for the year
-
(13,755,729)
(13,755,729)

Shares issued during the year
17,350,200
-
17,350,200


At 31 December 2023
21,372,905
(13,754,763)
7,618,142


The notes on pages 11 to 20 form part of these financial statements.

Page 10

 
VIVERSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Viverse Limited is a company limited by share capital, incorporated in England and Wales, registration number 14110898. The address of the registered office is Salamanca, Wellington Street, Slough, Berkshire, SL1 1YP.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies (see note 3).

The following principal accounting policies have been applied:

 
2.2

Financial Reporting Standard 102 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
the requirements of Section 7 Statement of Cash Flows;
the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d).

This information is included in the consolidated financial statements of HTC Corporation as at 31 December 2024 and these financial statements may be obtained from No. 1, Ln. 21, Xinghua Rd., Taoyuan Dist., Taoyuan City 330, Taiwan, R.O.C..

 
2.3

Exemption from preparing consolidated financial statements

The Company is a parent company that is also a subsidiary included in the consolidated financial statements of a larger group by a parent undertaking established under the law of a state other than the United Kingdom and is therefore exempt from the requirement to prepare consolidated financial statements under section 401 of the Companies Act 2006.

Page 11

 
VIVERSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.4

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of comprehensive income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

 
2.5

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.6

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.7

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.8

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Page 12

 
VIVERSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.9

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. 

 
2.11

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.12

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance sheet when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Impairment of financial assets

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The
Page 13

 
VIVERSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.12
Financial instruments (continued)

impairment reversal is recognised in the profit or loss.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Page 14

 
VIVERSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

3.


Judgments in applying accounting policies and key sources of estimation uncertainty

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Key accounting estimates and assumptions
The Company makes estimates and assumptions concerning the future. The resulting accounting estimates will, by definition, seldom equal the related actual results. The estimate and assumption that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are: 
Impairments of fixed asset investments
Determining whether the fixed asset investments are impaired requires a comparison between the underlying net assets of the subsidiaries and the carrying value of the investments. £8.69m impairment has been recognised as the directors have determined that the net assets of the subsidiaries are less than the carrying value of the investments. The carrying value of the investments is £17,063,576 (see Note 7).


4.


Operating profit/(loss)

The operating profit/(loss) is stated after charging:

2024
2023
£
£

Exchange differences
(12,112)
270,224


5.


Auditors' remuneration

During the year, the Company obtained the following services from the Company's auditors:


2024
2023
£
£

Fees payable to the Company's auditors for the audit of the Company's financial statements
9,171
4,071


6.


Employees




The average monthly number of employees, including the director, during the year was as follows:


        2024
        2023
            No.
            No.







Directors
1
1

Page 15

 
VIVERSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

7.


Interest receivable

2024
2023
£
£


Other interest receivable
13
18

13
18


8.


Interest payable and similar expenses

2024
2023
£
£


Other interest payable
-
5

-
5


9.


Taxation


2024
2023
£
£



Total current tax
-
-

Deferred tax

Total deferred tax
-
-


Tax on loss
-
-
Page 16

 
VIVERSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
 
9.Taxation (continued)


Factors affecting tax charge for the year

The tax assessed for the year is higher than (2023 - higher than) the standard rate of corporation tax in the UK of 25% (2023 - effective rate of  23.5%). The differences are explained below:

2024
2023
£
£


Loss on ordinary activities before tax
(8,686,434)
(13,755,729)


Loss on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2023 - effective rate of 23.5%)
(2,171,609)
(3,232,596)

Effects of:


Expenses not deductible for tax purposes, other than goodwill amortisation and impairment
2,171,882
3,167,252

Group loss surrendered
-
65,344

Group relief
(230)
-

Marginal relief
(43)
-

Total tax charge for the year
-
-

Page 17

 
VIVERSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

10.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 January 2024
20,262,455


Additions
18,962,640



At 31 December 2024

39,225,095



Impairment


At 1 January 2024
13,473,992


Charge for the period
8,687,527



At 31 December 2024

22,161,519



Net book value



At 31 December 2024
17,063,576



At 31 December 2023
6,788,463


Subsidiary undertakings


The following were subsidiary undertakings of the Company:

Name

Registered office

Class of shares

Holding

Viverse Limited
10 Ealsfort Terrace, Dublin, Dublin 2, Ireland
Ordinary
100%
Viveport Digital Corporation
11F, No. 88, Sec. 3, Zhongsing Rd., Xindian Dist., New Taipei City, 231, Taiwan
Ordinary
100%

Page 18

 
VIVERSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

11.


Debtors

2024
2023
£
£


Input VAT
2,740
-

Called up share capital not paid
1
1

2,741
1



12.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
842,837
838,740

842,837
838,740



13.


Creditors: Amounts falling due within one year

2024
2023
£
£

Other creditors
9,306
6,162

Accruals
5,500
2,900

14,806
9,062



14.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



40,335,545 (2023 - 21,372,905) Ordinary shares of £1.00 each
40,335,545
21,372,905


During the reporting period, the Company alloted and issued 18,962,640 ordinary shares at £1.00 each. All shares were paid in full in cash. 


15.


Reserves

Profit and loss account

The profit and loss account comprises the balance of profits accumulated over the life of the Company.

Page 19

 
VIVERSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

16.


Controlling party

The immediate parent of the company is Viverse Holding Corporation, a company incorporated in Cayman Islands.
In the opinion of the directors, the ultimate parent and controlling company is HTC Corporation, a company incorporated in Taiwan, Republic of China. 
The only group in which results are consolidated is that headed by HTC Corporation. The consolidated accounts of HTC Corporation are available for inspection at No. 23 Xinghua Rd,. Taoyuan City, Taoyuan County 330, Taiwan, R.O.C.

 
Page 20